Diagnostics
Nuclear medicine can help avoid unnecessary angioplasty

Nuclear medicine can help avoid unnecessary angioplasty

Mumbai: In an interview with DNA, Dr G N Mahapatra, head of department of non-invasive cardiology at Seven Hills Hospital, Mumbai explains how nuclear medicine can help avoid unnecessary angioplasty and why many cardiologists don’t prescribe it. more

Faulty gene identified as cause of obesity in world’s heaviest woman

Faulty gene identified as cause of obesity in world’s heaviest woman

New Delhi: A genetic mutation has been identified as the cause of obesity in 36-year-old Egyptian woman Eman Ahmed, who is believed to be the world’s heaviest woman, and is undergoing treatment in India to cure her morbid obesity. more

Dr Lal PathLabs to open central labs in Kolkata, Lucknow

Dr Lal PathLabs to open central labs in Kolkata, Lucknow

Mumbai: Dr Lal PathLabs, the oldest pathology lab chain in the country, plans to open a central lab in Kolkata in September, and another one in Lucknow by the end of 2018. Currently, it has one central lab in Delhi, besides 179 laboratories, most of them in north and east India. more

New blood test assists oncologists with tumour treatment optimization

New blood test assists oncologists with tumour treatment optimization

Washington: CellMax Life, a precision cancer blood-testing company, on Wednesday announced the availability of CellMax-LBx Liquid Biopsy in India. more

BD launches diagnostic instrument for rapid identification of bacteria and detection of antimicrobial resistance

BD launches diagnostic instrument for rapid identification of bacteria and detection of antimicrobial resistance

New Delhi: BD (Becton, Dickinson and Company), a global medical technology company, on Wednesday announced the launch of its next generation diagnostic instrument for the rapid identification of bacteria and detection of antimicrobial resistance (AMR). more

Respiratory diagnostics market expected to reach $7.45 billion by 2021

Respiratory diagnostics market expected to reach $7.45 billion by 2021

Pune: The global respiratory diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 7.3 percent and reach $7.45 billion by 2021 from $5.24 billion in 2016, according to a new market research report by MarketsandMarkets. more

Immunoassay market expected to reach $25.45 billion by 2021

Immunoassay market expected to reach $25.45 billion by 2021

Pune: The global immunoassay market is expected to grow at a CAGR of 8.2 per cent from $17.16 billion in 2016 to $25.45 billion by 2021, according to a new market research report by MarketsandMarkets. more

Point of care diagnostics market expected to reach $32.7 billion by 2022

Point of care diagnostics market expected to reach $32.7 billion by 2022

Pune: Global Point of Care Diagnostics Market is expected to grow at a CAGR (compound annual growth rate) of 9.7 percent to reach $32.7 billion by 2022, according to Wise Guy Reports. more

US FDA clears test to detect specific genetic markers for certain antibiotic-resistant bacteria

US FDA clears test to detect specific genetic markers for certain antibiotic-resistant bacteria

Washington: The US Food and Drug Administration on Wednesday cleared for marketing the Xpert Carba-R Assay, an infection control aid that tests patient specimens to detect specific genetic markers associated with bacteria that are resistant to Carbapenem antibiotics. more

Medanta hospital partners with Australian university to improve epilepsy diagnosis in Indian villages

Medanta hospital partners with Australian university to improve epilepsy diagnosis in Indian villages

New Delhi: Swinburne University of Technology, Melbourne, Australia has signed an agreement with Medanta – The Medicity hospital, Gurgaon to improve the diagnosis of epilepsy in villages and remote communities across India. more